Is administration of preoperative angiotensin-converting enzyme inhibitors important for renal protection after cardiac surgery?

Renal Failure

Volumn 35, Issue 5, 2013, Pages 754-760

  Dag, Ozgur ^a   Kaygin, Mehmet Ali ^a   Aydin, Ahmet ^a   Limandal, Husnu Kamil ^a   Arslan, Ümit ^a   Kiymaz, Adem ^a   Kahraman, Nail ^a   Calik, Eyup Serhat ^a   Erkut, Bilgehan ^a  

^a Erzurum Regional Training and Research Hospital   (Turkey)

Author keywords

CABG; Cardiac surgery; Cardiopulmonary bypass; Renal dysfunction; Renal failure

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CREATININE; DIGITALIS GLYCOSIDE; GLYCERYL TRINITRATE; LIDOCAINE; LOOP DIURETIC AGENT; RAMIPRIL;

ADULT; AGE; ANTIHYPERTENSIVE THERAPY; AORTA FLOW; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DRUG DOSE REGIMEN; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SURGERY; HEMATOCRIT; HEMODIALYSIS; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SURGICAL MORTALITY; SURGICAL PATIENT; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC SURGICAL PROCEDURES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RAMIPRIL; RENAL INSUFFICIENCY; RENIN-ANGIOTENSIN SYSTEM; RETROSPECTIVE STUDIES;

EID: 84877863170     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.777891     Document Type: Article

References (28)

1. Rady MY, Ryan T. The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery. Chest. 1998;114:487-494 (Pubitemid 28387528)
2. Baue AE. Multiple organ failure, multiple organ dysfunction syndrome and systemic inflammatory response syndrome: Why no magic bullets? Arch Surg. 1997;132:703-707 (Pubitemid 27305220)
3. Ryckwaert F, Colson P, Ribstein J, Boccara G, Guillon G. Hemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischemic heart dysfunction. Br J Anaesth. 2001;86:169-175 (Pubitemid 32103403)
4. American Heart Association. Heart Disease and Stroke Statistics: 2005 Uptake. Dallas, TX: American Heart Association; 2005
5. Benedetto U, Sciarretta S, Roscitano A, et al. Preoperative angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting. Ann Thorac Surg. 2008;86:1160-1166
6. Boldt J, Schindler E, Wollbruck M, et al. Cardiorespiratory response of intravenous Enalaprilat in hypertensive cardiac surgeiy patients. J Cardiothorac Vase Anesth. 1995;9:44-49
7. Mann JF, Gerstein HC, Yi QL, et al. Development of renal disease in people at high cardiovascular risk: Results of the HOPE randomized study. J Am Soc Nephrol. 2003;14:641-647 (Pubitemid 36246007)
8. Marre M, Lievre M, Chatellier G, Mann JF, Passa P, Ménard J. DIABHYCAR Study Investigators. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: Randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ. 2004;328:495-498
9. Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitorassociated elevations in serum creatinine: Is this a cause for concern? Arch Intern Med. 2000;160:685-693 (Pubitemid 30140419)
10. Böttiger BW, Rauch H, Böhrer H, et al. Continuous versus intermittent cardiac output measurement in cardiac surgical patients undergoing hypothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1995;9:405-411
11. Colson P, Ribstein J, Mimran A, Grolleau D, Chaptal PA, Roquefeuil B. Effect of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery. Anesthesiology. 1990;72:23-27 (Pubitemid 20031306)
12. Gottlieb SS, Weir MR. Renal effects of angiotensin converting enzyme inhibition in congestive heart failure. Am J Cardiol. 1990;66:14-21
13. Lonn EM, Yusuf S, Jha P, et al. Emerging role of angiotensin converting enzyme inhibitors in cardiac and vascular protection. Circulation. 1994;90:2056-2069 (Pubitemid 24320959)
14. Lyons D, Webster J, Benjamin N. Adrenergic sympathetic constrictor action in humans. Circulation. 1995;91: 1457-1459
15. Gamoso MG, Phillips-Bute B, Landolfo KP, Newman MF, Stafford-Smith M. Off-pump versus on-pump coronary artery bypass surgery and postoperative renal dysfunction. Anesth Analg. 2000;91:1080-1084
16. Wagner F, Yeter R, Bisson S, Siniawski H, Hetzer R. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction. Crit Care Med. 2003;31:1421-1428 (Pubitemid 36583854)
17. Argenziano M, Chen JM, Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg. 1998;116:973-980 (Pubitemid 28553541)
18. Mehta RH, Grab JD, O'Brien SM, et al. Society of Thoracic Surgeons National Cardiac Surgery Database Investigators. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation. 2006;114:2208-2216 (Pubitemid 44789495)
19. Brown JR, Cochran RP, Leavitt BJ, et al. Northern New England Cardiovascular Disease Study Group. Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation. 2007;116:I139-I143 (Pubitemid 47480782)
20. Thakar CV, Worley S, Arrigain S, Yared JP, Paganini EP. Influence of renal dysfunction on mortality after cardiac surgery: Modifying effect of preoperative renal function. Kidney Int. 2005;67:1112-1119 (Pubitemid 41623337)
21. Thakar CV, Worley S, Arrigain S, Yared JP, Paganini EP. Improved survival in acute kidney injury after cardiac surgery. Am J Kidney Dis. 2007;50:703-711 (Pubitemid 47588554)
22. Wijeysundera DN, Karkouti K, Dupuis JY, et al. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. J Am Med Assoc. 2007;297:1801-1809 (Pubitemid 46658649)
23. Topkara VK, Cheema FH, Kesavaramanujam S, et al. Coronary artery bypass grafting in patients with low ejection fraction. Circulation. 2005;112:I344-I350 (Pubitemid 41266697)
24. Andersen S, Tarnow L, Cambien F, et al. Long-Term renoprotective effects of losartan in diabetic nephropathy: Interaction with ACE insertion/deletion genotype? Diabetes Care. 2003;26 (5):1501-1506 (Pubitemid 36929186)
25. Ljutić D, Kes P. The role of arterial hypertension in the progression of non-diabetic glomerular diseases. Nephrol Dial Transplant. 2003;18(Suppl. 5):28-30
26. Kes P, Basić-Jukić N, Ljutić D, Brunetta- Gavranić B. The role of arterial hypertension in developement of chronic renal failure. Acta Med Croatica. 2011;65(Suppl. 3):78-84
27. Mansoor AM, Honda M, Kuramochi T, et al. Effects of ACE inhibition and beta-blockade on collagen remodeling in the heart of Bio 14.6 hamsters. Clin Exp Pharamacol Physiol. 1996;23: 43-49 (Pubitemid 126423404)
28. Patten RD, Kronenberg MW, Benedict CR, et al. Acute and long-Term effects of the angiotensin converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction. Am Heart J. 1997;134:37-43 (Pubitemid 27329021)